The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier&Rice to sell ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

Sanofi said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer ...

Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

EDITORIAL. French pharmaceutical company Sanofi's plan to sell 50% of Opella, which produces France's favorite drug, to an ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...

In French pharmacies, the brand's colourful boxes often line entire shelf walls, and Doliprane comes in many doses – from 100 mg for newborn babies to 1,000 mg for adults – and in tablet ...